A Modern Approach to
Cancer Testing

IONIQ Sciences is at the forefront of early cancer detection

Cancer is a scourge on society. One in two Americans will be diagnosed with cancer during their lifetime and one in five will die. The five-year cancer survival rates approach 90% when diagnosed in the earliest stages of the disease versus just 10% in the latest stages. 

We believe it doesn’t have to be this way. 

Expanding from a Single Cancer
Test to a
Multi-Cancer Screen

Early detection saves lives and money by detecting cancer at its earliest, most-treatable stages. We are well-positioned to develop a Multi-Cancer Screen by leveraging our lung test, breast test, proprietary technology, substantial EIA database, and our deep clinical experience.

IONIQ Development Pipeline

ProLung Test (Lung Cancer)
Breast Cancer Test
Multi-Cancer Screen

Clinical Data

Assembled a deep clinical evidence library with data collected from more than 1,200 subjects

Premier Clinical Sites

More than 20 premier cancer institutions around the world participated in our clinical trials

Awarded Breakthrough Device Designation

IONIQ's ProLung Test was awarded “Breakthrough Device Designation” by US FDA for its life-enhancing potential

Intellectual Property

Robust, growing intellectual portfolio of patents and know-how

15 yrs
in the Making

IONIQ Recent News

IONIQ hosts Salt Lake City Mayor Mendenhall at its Office

Salt Lake City, UT, May 2, 2022 – IONIQ Sciences, Inc. (“IONIQ” or the “Company”) was honored to welcome Salt Lake City Mayor Mendenhall to its office today. During the Mayor’s visit, Michael Garff, IONIQ COO, shared how the Company is developing a Multi-Cancer Screen to help physicians

IONIQ Sciences hires Edison Group as Investor Relations Advisor

Salt Lake City, UT, March 17, 2022 – IONIQ Sciences, Inc. (“IONIQ” or the “Company”) announced today that it has hired Edison Group, a leading investor relations and research firm, to assist with its investor relations program. Edison Group, established in 2003, is an investor relations, investor

Standards & Certifications

Meet the Team

Proud to be part of BioHive, the Nations Fastest Growing Life Science Hub.

By embracing diversity and collaboration, BioHive has become the fastest-growing life science community in America. And our innovations are improving the lives of millions of patients.